Photocure ASA
OSE:PHO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Colt CZ Group SE
OTC:CZGZF
|
CZ |
Photocure ASA
Total Current Liabilities
Photocure ASA
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Photocure ASA
OSE:PHO
|
Total Current Liabilities
kr105.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
V
|
Vistin Pharma ASA
OSE:VISTN
|
Total Current Liabilities
kr79m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
2%
|
|
|
N
|
Navamedic ASA
OSE:NAVA
|
Total Current Liabilities
kr187.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
|
S
|
SoftOx Solutions AS
OSE:SOFTX
|
Total Current Liabilities
kr13.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
O
|
Oncoinvent ASA
OSE:ONCIN
|
Total Current Liabilities
kr19.7m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Photocure ASA
Glance View
Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.
See Also
What is Photocure ASA's Total Current Liabilities?
Total Current Liabilities
105.9m
NOK
Based on the financial report for Dec 31, 2025, Photocure ASA's Total Current Liabilities amounts to 105.9m NOK.
What is Photocure ASA's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
12%
Over the last year, the Total Current Liabilities growth was 2%. The average annual Total Current Liabilities growth rates for Photocure ASA have been 1% over the past three years , 6% over the past five years , and 12% over the past ten years .
